Persistent respiratory symptoms and lung function abnormalities in recovered patients of COVID-19

被引:0
|
作者
Vishnu, N. S. [1 ]
Sodhi, Mandeep K. [1 ,3 ]
Aggarwal, Deepak [1 ]
Puri, Sonia [2 ]
Saini, Varinder [1 ]
机构
[1] Govt Med Coll & Hosp, Dept Pulm Crit Care & Sleep Med, Sect 32, Chandigarh, India
[2] Govt Med Coll & Hosp, Dept Community Med, Sect 32, Chandigarh, India
[3] Govt Med Coll & Hosp, Dept Pulm Crit Care & Sleep Med, D Block level 5,Sect 32, Chandigarh, India
关键词
Complications; COVID-19; persistent symptoms; pulmonary function; risk factors; CORONAVIRUS DISEASE 2019; CONSEQUENCES; PREVALENCE;
D O I
10.4103/lungindia.lungindia_166_23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and Objectives: COVID-19 is a disease caused by SARS-CoV-2 which belongs to a family of coronaviruses. After the acute phase of illness, the majority of the patients recover quickly but, in some cases, symptoms can persist for a variable duration, bringing into light another entity known as post-COVID syndrome. The objective was to estimate the burden of various persistent respiratory symptoms and lung function abnormalities among recovered patients of COVID-19 and also to correlate them with initial disease severity, demographic factors and comorbidities. Methods: Eighty-five post-COVID patients were recruited as per inclusion/exclusion criteria. Detailed history taking, physical examination and spirometry were done in all patients and data were correlated with baseline disease severity. Results: Fatigue and breathlessness were the most common symptoms followed by cough, chest pain and fever. Persistent symptoms and their severity were significantly higher in severe/moderate cases. Spirometry was abnormal in 45.88% of subjects and the most common pattern was restrictive type. It was seen that the likelihood of persistent symptoms and abnormal lung function increased significantly with the severity of COVID-19, age, comorbidities, hospital stay duration and steroid/oxygen therapy. Conclusion: The current study estimated the burden and array of various pulmonary sequelae encountered by post-COVID patients and elicited various risk factors associated with their occurrence after recovery from active infection. Awareness of these symptoms/sequelae and their risk factors is necessary for their follow-up and timely management, as the threat of this relatively new virus has still not abated.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 50 条
  • [1] Persistent symptoms and lab abnormalities in patients who recovered from COVID-19
    Julian Varghese
    Sarah Sandmann
    Kevin Ochs
    Inga-Marie Schrempf
    Christopher Frömmel
    Martin Dugas
    Hartmut H. Schmidt
    Richard Vollenberg
    Phil-Robin Tepasse
    [J]. Scientific Reports, 11
  • [2] Persistent symptoms and lab abnormalities in patients who recovered from COVID-19
    Varghese, Julian
    Sandmann, Sarah
    Ochs, Kevin
    Schrempf, Inga-Marie
    Froemmel, Christopher
    Dugas, Martin
    Schmidt, Hartmut H.
    Vollenberg, Richard
    Tepasse, Phil-Robin
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Profile of COVID-19 Patients with Persistent Respiratory Symptoms
    Harsha, P. V.
    Balagopalan, Durga
    Aneesh, M. M.
    James, Ponneduthamkuzhy Thomas
    Bhaskar, Ajit
    Krishnaveni, S.
    [J]. INDIAN JOURNAL OF RESPIRATORY CARE, 2023, 12 (01) : 55 - 58
  • [4] Delayed lung function testing after COVID-19 to detect persistent lung function abnormalities - The DELTA - COVID-19 lung function study
    Nirmal, Aparna S.
    Venkitakrishnan, Rajesh
    Augustine, Jolsana
    Divya, R.
    Cleetus, Melcy
    Vijay, Anand
    John, Susan
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (11) : 7351 - 7356
  • [5] Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients
    Giulia Besutti
    Paolo Giorgi Rossi
    Marta Ottone
    Lucia Spaggiari
    Simone Canovi
    Filippo Monelli
    Efrem Bonelli
    Tommaso Fasano
    Nicola Sverzellati
    Andrea Caruso
    Nicola Facciolongo
    Giulia Ghidoni
    Anna Simonazzi
    Mauro Iori
    Andrea Nitrosi
    Stefania Fugazzaro
    Stefania Costi
    Stefania Croci
    Elisabetta Teopompi
    Annalisa Gallina
    Marco Massari
    Giovanni Dolci
    Fabio Sampaolesi
    Pierpaolo Pattacini
    Carlo Salvarani
    [J]. Scientific Reports, 12
  • [6] Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients
    Besutti, Giulia
    Giorgi Rossi, Paolo
    Ottone, Marta
    Spaggiari, Lucia
    Canovi, Simone
    Monelli, Filippo
    Bonelli, Efrem
    Fasano, Tommaso
    Sverzellati, Nicola
    Caruso, Andrea
    Facciolongo, Nicola
    Ghidoni, Giulia
    Simonazzi, Anna
    Iori, Mauro
    Nitrosi, Andrea
    Fugazzaro, Stefania
    Costi, Stefania
    Croci, Stefania
    Teopompi, Elisabetta
    Gallina, Annalisa
    Massari, Marco
    Dolci, Giovanni
    Sampaolesi, Fabio
    Pattacini, Pierpaolo
    Salvarani, Carlo
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
    Yoshiharu Miyata
    Kohjin Suzuki
    Tatsuya Nagano
    Keiji Iida
    Takehiro Hasegawa
    Hitoshi Uga
    Hiroshi Matsuoka
    [J]. Scientific Reports, 13
  • [8] Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
    Miyata, Yoshiharu
    Suzuki, Kohjin
    Nagano, Tatsuya
    Iida, Keiji
    Hasegawa, Takehiro
    Uga, Hitoshi
    Matsuoka, Hiroshi
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Persistent symptoms, lung function and imaging abnormalities at 1-year follow-up for severe COVID-19
    Solis-Diaz, Luis Alberto
    Mateos-Toledo, Heideger Norberto
    Figueroa-Hurtado, Esperanza
    Ortiz Farias, Diana Lizbeth
    Pou-Aguilar, Yuri Noemi
    Vazquez-Lopez, Saul
    Cortes-Telles, Arturo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Delayed Symptoms in Patients Recovered from COVID-19
    Moradian, Seyed Tayeb
    Parandeh, Akram
    Khalili, Robabe
    Karimi, Leila
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (11) : 2120 - 2127